All Stories

  1. From acute mast cell activation to a structured immunothrombotic and autoimmune niche in chronic spontaneous urticaria
  2. The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper
  3. Clinical phenotypes and molecular endotypes of chronic urticaria: Linking clinical expression to underlying immune mechanisms
  4. Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study
  5. JAK inhibitors in livedoid vasculopathy associated with thrombophilia and refractory to anticoagulation: report and literature review
  6. The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
  7. Family quality‐of‐life burden in chronic spontaneous urticaria: A multicentre study
  8. Autoimmune progesterone dermatitis: diagnostic relevance and epidemiological analysis of 13 cases
  9. The OX40-OX40L Co-stimulatory pathway in dermatology: emerging frontiers for therapeutic approaches
  10. The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE‐D Study
  11. Chronic spontaneous urticaria: update on pathogenesis and therapeutic implications
  12. Urticária crônica espontânea: atualização na patogênese e implicações terapêuticas
  13. Dermatose terra firma‐forme exuberante em paciente idoso
  14. Exuberant terra firma-forme dermatosis in an elderly patient⋆
  15. Chronic pruritus: a narrative review
  16. Prurido crônico: revisão narrativa
  17. IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria
  18. DRESS syndrome: an interaction between drugs, latent viruses, and the immune system
  19. Update on the pathogenesis of atopic dermatitis
  20. Treatment with risankizumab for nivolumab‐induced psoriasis in a patient with metastatic clear cell renal carcinoma
  21. Prurigo: review of its pathogenesis, diagnosis, and treatment
  22. Bibliometric evaluation of Anais Brasileiros de Dermatologia (2013-2022)
  23. Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study
  24. Association of non-fatal symmetrical peripheral gangrene and COVID-19
  25. Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses
  26. How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
  27. New small molecules in dermatology: for the autoimmunity, inflammation and beyond
  28. JAK-STAT pathway inhibitors in dermatology
  29. Prevalence of filaggrin gene polymorphisms (exon-3) in patients with atopic dermatitis in a multiracial Brazilian population
  30. Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy
  31. Livedoid Vasculopathy: Clinical, Histopathological, and Therapy Evaluation
  32. Primary Cutaneous Cryptococcosis Caused by Cryptococcus gatti in an Elderly Patient
  33. Pityriasis rubra pilaris (type I) following ChAdOx1 COVID‐19 vaccine: A report of two cases with successful treatment with oral isotretinoin
  34. Vasculitis in the setting of COVID ‐19: from the disease to the vaccine. Report of a case of cutaneous vasculitis after immunization
  35. Post‐COVID‐19 hair loss: prevalence and associated factors among 5,891 patients
  36. Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial
  37. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
  38. M2 macrophage polarization in chronic spontaneous urticaria refractory to antihistamine treatment
  39. Allergic contact dermatitis by ophthalmological medications in Brazil: experience of a dermatology department
  40. COVID‐19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria
  41. Chromoblastomycosis evolving to sarcomatoid squamous cell carcinoma: A case report
  42. Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals
  43. What lessons can we learn? Clinical and epidemiological retrospective analysis of 267 patients with urticaria in a Brazilian tertiary center
  44. Urticarial vasculitis revealing immunolabelled nucleocapsid protein of SARS‐CoV‐2 in two Brazilian asymptomatic patients: the tip of the COVID‐19 hidden iceberg?
  45. International registry of dermatological manifestations secondary to COVID‐19 infection in 347 Hispanic patients from 25 countries
  46. A case of tuberculosis verrucosa cutis in Brazil undiagnosed for 15 years
  47. First report of cutaneous mycetoma by Paecilomyces variotii and the successful treatment with combined itraconazole and terbinafine along with resection surgeries
  48. A late diagnosis of hyperhomocysteinemia with probable evolution to verrucous elephantiasis nostra and leg ulcers
  49. Axillary papules: an uncommon location of lichen nitidus
  50. Evaluation of serum levels of C-reactive protein, D-Dimer and Autologous Serum Skin Test in patients with Chronic Spontaneous Urticaria in a Brazilian tertiary center : a cross-sectional study
  51. Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice
  52. Livedoid vasculopathy in 75 Brazilian patients in a single‐center institution: Clinical, histopathological and therapy evaluation
  53. The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria
  54. Sarcoidosis with necrobiosis‐lipoidica–like skin lesions: A challenge for the dermatologist
  55. Granuloma Annulare: a Review of the Literature
  56. From dermatological conditions to COVID ‐19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy
  57. Case Report: An Uncommon Clinical Case of Fatal Adult T-Cell Leukemia/Lymphoma Associated with HTLV-1 and Suspected due to Cutaneous Lesions and Epidemiologic Data
  58. Case Report: Treatment of Chromoblastomycosis with Combinations including Acitretin: A Report of Two Cases
  59. Potential interactions of SARS‐CoV‐2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues
  60. Less is more: study on the different ways of closing surgical wounds after Mohs micrographic surgery
  61. Termo de consentimento informado: impacto na decisão judicial
  62. Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab
  63. What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID ‐19 or asymptomatic infections due to SARS‐CoV ‐2?
  64. Lessons from dermatology about inflammatory responses in Covid‐19
  65. Unilateral verrucous plaque in a 14‐year‐old child
  66. Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis
  67. Grammatically uniform population initialization for grammar-guided genetic programming
  68. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
  69. Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability
  70. Panniculitis as main clinical manifestation of alpha‐1 antitrypsin deficiency revealing a SerpinA1 gene mutation
  71. Botryomycosis in Patient With Pituitary Microadenome: A Case Report
  72. Multinucleate cell angiohistiocytoma: an uncommon cutaneous tumor in private practice
  73. Update on vasculitis: overview and relevant dermatological aspects for the clinical and histopathological diagnosis – Part II
  74. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  75. Clinical variability of the GJB4: c.35G > A gene variant : a study of a large Brazilian erythrokeratodermia pedigree
  76. Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis – part I
  77. A Rare Case of Multiple Variants of Porokeratosis in the Same Patient: The Clue of Dermoscopy for Diagnosis and Therapeutical Update
  78. Livedo Racemosa: Clinical, Laboratory, and Histopathological Findings in 33 Patients
  79. Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod
  80. Diagnóstico e terapêutica precoce de vasculite leucocitoclástica: relato de caso
  81. Atypical clinical presentation of an Arthroderma gypseum infection in a renal transplant recipient
  82. Correlation Between Demographic and Tumor Characteristics in Non-melanoma Skin Cancers Submitted to Mohs Micrographic Surgery
  83. Trichophyton rubrum Elicits Phagocytic and Pro-inflammatory Responses in Human Monocytes Through Toll-Like Receptor 2
  84. Is macular lymphocytic arteritis limited to the skin? Long-term follow-up of seven patients
  85. Characterization of subtypes of Blastocystis sp. isolated from patients with urticaria, São Paulo, Brazil
  86. Ungual warts: comparison of treatment with intralesional bleomycin and electroporation in terms of efficacy and safety
  87. Panniculitides of particular interest to the rheumatologist
  88. Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults - Brazilian Society of Dermatology
  89. Association between frontal fibrosing alopecia and linear scleroderma “coup de sabre”
  90. What lessons can we learn from an apparent decrease in the use of topical drugs for psoriasis?
  91. In situ immune response in human dermatophytosis: possible role of Langerhans cells (CD1a+) as a risk factor for dermatophyte infection
  92. Radiotherapy-induced Pemphigus Foliaceous: a rare adverse effect of breast cancer therapy
  93. The train tracks sign is a valuable skin marker of envenomations caused by caterpillars
  94. Immunological Pathways in Hidradenitis Suppurativa: Current Concepts and Innovative Therapies
  95. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban
  96. Comparison of diagnostic methods to detect Histoplasma capsulatum in serum and blood samples from AIDS patients
  97. Histopathological and clinical evaluation of chronic spontaneous urticaria patients with neutrophilic and non-neutrophilic cutaneous infiltrate
  98. Livedoid vasculopathy: a compelling diagnosis
  99. Skin cancer prevention campaign in childhood: survey based on 3676 children in Brazil
  100. Recurrent and disseminated pityriasis versicolor: A novel clinical form consequent to Malassezia -host interaction?
  101. Analysis of serum levels and cutaneous expression of Lipoprotein (a) in 38 patients with livedoid vasculopathy
  102. Longitudinal melanonychia due to voriconazole therapy during treatment of chromoblastomycosis
  103. Investigation of superficial mycosis in cutaneous allergy patients using topical or systemic corticosteroids
  104. Urticaria multiforme: Two cases with histopathological findings
  105. Hemodialysis and Kidney Transplantation as Predisposing Conditions to Onychomycosis
  106. Polymorphisms on IFNG , IL12B and IL12RB1 genes and paracoccidioidomycosis in the Brazilian population
  107. Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall
  108. Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: Report of 22 cases and literature review
  109. Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital
  110. Use of Smartphones in Telemedicine: Comparative Study Between Standard and Teledermatological Evaluation of High-Complex Care Hospital Inpatients
  111. Thrombophilia: the dermatological clinical spectrum
  112. Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor?
  113. Amantadine-Induced Livedo Racemosa
  114. Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor?
  115. Chronic widespread dermatophytosis due to Trichophyton rubrum: a syndrome associated with a Trichophyton-specific functional defect of phagocytes
  116. Nail Sarcoidosis with and without Systemic Involvement: Report of Two Cases
  117. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol
  118. Chronic urticaria in adults: state-of-the-art in the new millennium
  119. TOLL-LIKE RECEPTORS (TLR) 2 AND 4 EXPRESSION OF KERATINOCYTES FROM PATIENTS WITH LOCALIZED AND DISSEMINATED DERMATOPHYTOSIS
  120. Monocyte-Derived Dendritic Cells from Patients with Dermatophytosis Restrict the Growth of Trichophyton rubrum and Induce CD4-T Cell Activation
  121. Atrophie Blanche
  122. Quality-of-life impairment in patients with livedoid vasculopathy
  123. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody
  124. In Situ Immune Response in Human Chromoblastomycosis – A Possible Role for Regulatory and Th17 T Cells
  125. Cutaneous New World Leishmaniasis on a Port-wine stain birthmark
  126. Elevated Levels of Coagulation Factor VIII in Patients With Venous Leg Ulcers
  127. Plasmacytoid dendritic cells in cutaneous lesions of patients with chromoblastomycosis, lacaziosis, and paracoccidioidomycosis: a comparative analysis
  128. Topical Application of Imiquimod as a Treatment for Chromoblastomycosis
  129. Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach
  130. Dermoscopy examination of petechial lesions in a patient with Dermatitis Herpetiformis
  131. Unilateral Livedoid Vasculopathy Associated With Involutional Phase of Cutaneous Infantile Hemangioma
  132. Tungiasis under dermoscopy: in vivo and ex vivo examination of the cutaneous infestation due to Tunga penetrans
  133. Cutaneous Manifestations and Comorbidities in 60 Cases of Takayasu Arteritis
  134. Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis
  135. Direct immunofluorescence findings and thrombophilic factors in livedoid vasculopathy: how do they correlate?
  136. Cutaneous Manifestations and Comorbidities in 60 Cases of Takayasu Arteritis
  137. Dermoscopy revealing a case of Tinea Nigra*
  138. The use of nested Polymerase Chain Reaction (nested PCR) for the early diagnosis of Histoplasma capsulatum infection in serum and whole blood of HIV-positive patients*
  139. Autoimmunity Diseases of the Skin
  140. Topical photoprotection in childhood and adolescence
  141. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts
  142. Immunoelectron microscopy study of superficial skin nerves in drug-induced acute urticaria
  143. Dermal dendrocytes FXIIIA+ phagocytizing extruded mast cell granules in drug-induced acute urticaria
  144. Back to our past...
  145. Association between multiple skin tags and insulin resistance
  146. Association of acanthosis nigricans and skin tags with insulin resistance
  147. Analysis of the Expression of Toll-like Receptors 2 and 4 in Keratinocytes of Patients with Extensive Dermatophytosis due Trichophyton rubrum
  148. Candida parapsilosiscandidaemia in a neonatal unit over 7 years: a case series study
  149. Vasculopatia livedoide: uma doença cutânea intrigante
  150. Micoses superficiais e os elementos da resposta imune
  151. Balanite plasmocitária de Zoon: relato de dois casos tratados com pimecrolimo
  152. Urticaria and dermographism in patients with adult-onset Still’s disease
  153. Aos Editores dos Anais Brasileiros de Dermatologia (Brazilian Annals of Dermatology)
  154. Livedoid vasculopathy secondary to high levels of lipoprotein(a)
  155. Entodermoscopia: dermatoscopia de epiluminescência para diagnose da pediculose
  156. Livedoid vasculopathy as a coagulation disorder
  157. Cimidíase (dermatose por percevejo): uma causa de prurigo a ser lembrada
  158. Bedbugs (Cimicidae infestation): the worldwide renaissance of an old partner of human kind
  159. E-learning program for medical students in dermatology
  160. Blefarite e tricomegalia induzidas pelo cetuximabe
  161. Avaliação clínica, dermatoscópica e histopatológica do nevo de Meyerson: relato de caso
  162. Reações tegumentares adversas relacionadas aos agentes antineoplásicos: parte II
  163. Reações tegumentares adversas relacionadas aos agentes antineoplásicos: parte I
  164. Cromoblastomicose: relato de 27 casos e revisão da literatura
  165. Tratamento do papiloma vírus humano na infância com creme de imiquimode a 5%
  166. Extensive long-standing chromomycosis due toFonsecaea pedrosoi: Three cases with relevant improvement under voriconazole therapy
  167. Ixodíase revelada pela microscopia de epiluminescência sem contato com a pele
  168. Histamina, receptores de histamina e anti-histamínicos: novos conceitos
  169. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs - a prospective study
  170. Dermatite verrucosa de Pedroso e Gomes (Cromomicose): 90 anos depois, ainda entre nós
  171. Teledermatologia: correlação diagnóstica em serviço primário de saúde
  172. Multiple pustules on trunk, face, oral mucosa, genital area, palms and soles, arthalgia and anterior chest wall osteitis
  173. A comparative study of single-dose treatment of chancroid using thiamphenicol versus Azithromycin
  174. Monocyte-derived dendritic cells from patients with severe forms of chromoblastomycosis induce CD4+T cell activationin vitro
  175. Doações
  176. Vasculites dos médios e grandes vasos
  177. Prevalence of thrombophilia associated with leg ulcers
  178. S.138. Waldenstrom Hyperglobulinemic Purpura in a Patient with Chronic Mucocutaneous Candidiasis
  179. Manifestações cutâneas das trombofilias
  180. Fusariose em paciente imunocomprometido: sucesso terapêutico com voriconazol
  181. Influence of the human activity in the Atlantic Forest and in the prevalence of etiological agents of dermatophytosis in a coastal city of Southern Brazil Ubatuba (So Paulo)
  182. Urticaria unresponsive to antihistaminic treatment: An open study of therapeutic options based on histopathologic features
  183. Blisters on the legs
  184. Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin
  185. Thalidomide inhibits human ultraviolet-B-induced skin inflammation?
  186. An unusual association between scalp psoriasis and ophiasic alopecia areata: the Renbök phenomenon
  187. Childhood-onset skin necrosis resulting from protein C deficiency
  188. The inflammatory response in drug-induced acute urticaria: ultrastructural study of the dermal microvascular unit
  189. Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy
  190. Urticaria as a Cutaneous Sign of Adult-Onset Still's Disease
  191. Atrophia maculosa varioliformis cutis: a case with extrafacial involvement and familial facial lesions
  192. Tinea Faciei in an Infant Caused by Microsporum gypseum Simulating a Dry Impetigo
  193. Extensive nodular cutaneous amyloidosis: an unusual presentation
  194. Drug-Induced Hypersensitivity Syndrome Due to Anticonvulsants in a Two-Year-Old Boy
  195. Reações cutâneas graves adversas a drogas: aspectos relevantes ao diagnóstico e ao tratamento - Parte II
  196. Two case reports of cutaneous adverse reactions following hepatitis B vaccine: lichen planus and granuloma annulare
  197. Tinea Nigra: Report of Two Cases in Infants
  198. Acute generalized exanthematous pustulosis induced by ingestion of bamifylline
  199. Lichen sclerosus - a keratotic variant
  200. Necrobiotic xanthogranuloma with lambda paraproteinemia: case report of successful treatment with melphalan and prednisone
  201. Keratosis lichenoides chronica: Report of a case developing after erythroderma
  202. Invasive hyalohyphomycosis due to Fusarium solani in a patient with acute lymphocytic leukemia
  203. 10.1016/j.abdp.2024.10.017
  204. 10.1016/j.abdp.2024.08.001
  205. 10.1016/j.abdp.2024.03.001
  206. 10.1016/j.abdp.2023.10.001
  207. 10.1016/j.abdp.2023.05.018
  208. 10.1016/j.abdp.2020.09.027
  209. 10.1016/j.abdp.2020.12.003
  210. 10.1016/j.abdp.2020.04.012
  211. 10.1016/j.abdp.2020.07.014
  212. 10.1016/j.abdp.2020.04.011
  213. 10.1016/j.abdp.2020.08.009
  214. 10.1016/j.abdp.2020.05.019
  215. 10.1016/j.abdp.2020.05.005
  216. 10.1016/j.abdp.2020.04.003
  217. 10.1016/j.abdp.2020.01.004
  218. 10.1016/j.abdp.2019.05.001
  219. Urticária e doenças sistêmicas
  220. Melanoma maligno cutâneo primário: estudo retrospectivo de 1963 a 1997 no Hospital do Servidor Público Estadual de São Paulo
  221. DEEP FUNGAL INFECTIONS